Dr Stephen Thompson Emeritus Professor Colin Self
| Light-activated antibodies in the fight against primary and metastatic cancer | 2010 |
|
Dr Stephen Thompson
| Immunoprecipitation and Blotting | 2009 |
|
Dr Stephen Thompson John Dessi Emeritus Professor Colin Self
| Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics | 2009 |
|
Dr Stephen Thompson
| Small molecule-Protein conjugation procedures | 2009 |
|
Dr Stephen Thompson John Dessi Emeritus Professor Colin Self
| The construction and in vitro testing of photo-activatable cancer targeting folated anti-CD3 conjugates | 2008 |
|
Dr Stephen Thompson Robert Stewart Emeritus Professor Colin Self
| Light activation of Anti-CD3 in vivo reduces the growth of an aggressive ovarian carcinoma | 2007 |
|
Emeritus Professor Colin Self Dr Stephen Thompson
| Light-directed activation of human T-Cells | 2007 |
|
Dr Stephen Thompson Marie-claude Fawcett Emeritus Professor Colin Self
| The construction of a functional photoactivatable cancer targeting bispecific antibody conjugate | 2007 |
|
Dr Stephen Thompson Marie-claude Fawcett Emeritus Professor Colin Self
| A simple procedure for the photoregulation of chymotrypsin activity | 2006 |
|
Emeritus Professor Colin Self Dr Stephen Thompson
| How specific are therapeutic monoclonal antibodies? | 2006 |
|
Emeritus Professor Colin Self Dr Stephen Thompson
| Light activatable antibodies: Models for remotely activatable proteins | 1996 |
|
Dr Stephen Thompson Professor Andrew Pearson
| The possible use of serum MHC class-II levels for monitoring GRAFT-versus-host disease in bone marrow transplant recipients | 1988 |
|